Karni et al. report in this issue that proteins in the SR family, which modify gene function by alternative splicing, are among the many factors that can transform mammalian cells to malignancy. These splicing proteins regulate alternative splicing of many known proto-oncogenes and tumor-suppressor genes, thereby activating them post-transcriptionally to allow cells to escape normal controls on cell growth and proliferation.
This is a preview of subscription content, log in via an institution to check access.
Kim Caeser
References
Karni, R. et al. Nat. Struct. Mol. Biol. 14, 185–193 (2007).
Black, D.L. Annu. Rev. Biochem. 72, 291–336 (2003).
Jiang, Z.H. & Wu, J.Y. Proc. Soc. Exp. Biol. Med. 220, 64–72 (1999).
Faustino, N.A. & Cooper, T.A. Genes Dev. 17, 419–437 (2003).
Cartegni, L., Chew, S.L. & Krainer, A.R. Nat. Rev. Genet. 3, 285–298 (2002).
Lin, S. & Fu, X. D. in Alternative Splicing in the Postgenomic Era (eds. Blencowe, B. & Graveley, B.) (Eurekah Bioscience Collection, Landes Bioscience, Austin, Texas, USA, in the press).
Xu, X. et al. Cell 120, 59–72 (2005).
Ghigna, C. et al. Mol. Cell 20, 881–890 (2005).
Li, X. & Manley, J.L. Cell 122, 365–378 (2005).
Li, H.R. et al. Cancer Res. 66, 4079–4088 (2006).
Cartegni, L. & Krainer, A.R. Nat. Struct. Biol. 10, 120–125 (2003).
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Hu, A., Fu, XD. Splicing oncogenes. Nat Struct Mol Biol 14, 174–175 (2007). https://doi.org/10.1038/nsmb0307-174
Issue Date:
DOI: https://doi.org/10.1038/nsmb0307-174
- Springer Nature America, Inc.